Retirement Financial Solutions’s GSK GSK Stock Holding History

Retirement Financial Solutions’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-54	Closed	-$1.9K	–	105
2022 Q4	$1.9K	Buy	+54	New	+$1.8K	﹤0.01%	218

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Retirement Financial Solutions's GSK Position: Q1 2023 in Review

Retirement Financial Solutions sold out of GSK (GSK) in Q1 2023, closing a stake of 54 shares — an estimated $1.9K sold.

Retirement Financial Solutions first reported a position in GSK in Q4 2022 and held it in 1 quarter. The position peaked at $1.9K in Q4 2022. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

Retirement Financial Solutions reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
Retirement Financial Solutions sold 54 GSK shares in Q1 2023, an estimated $1.9K.
Retirement Financial Solutions first reported a position in GSK in Q4 2022 and held it in 1 quarter.
Retirement Financial Solutions's GSK position peaked at $1.9K in Q4 2022.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Retirement Financial Solutions's 13F filing for Q1 2023, filed 26 Apr 2023.